Filtered By:
Drug: Humira
Management: Insurance

This page shows you your search results in order of date.

Order by Relevance | Date

Total 2 results found since Jan 2013.

New Analyses Suggest Favorable Results for STELARA ® (ustekinumab) When Used as a First-Line Therapy for Bio-Naïve Patients with Moderately to Severely Active Crohn’s Disease and Ulcerative Colitis
SPRING HOUSE, PENNSYLVANIA, October 25, 2021 – The Janssen Pharmaceutical Companies of Johnson & Johnson today announced data from two new analyses of STELARA® (ustekinumab) for the treatment of adults with moderately to severely active Crohn’s disease (CD) and ulcerative colitis (UC).1,2 In a modelled analysisa focused on treatment sequencing using data from randomized controlled trials, network meta-analysis and literature, results showed patient time spent in clinical remission or response was highest when STELARA was used as a first-line advanced therapy for bio-naïve patients with moderately to severely acti...
Source: Johnson and Johnson - October 25, 2021 Category: Pharmaceuticals Tags: Innovation Source Type: news

Feeding Felix: overcoming an early onset of Crohn’s disease
Felix At just 3-months-old, Felix’s stool was regularly showing traces of blood. Alarmed, his mother Jessica Hsu quickly brought her young son to see his pediatrician, who referred Felix to be seen by Boston Children’s Hospital pediatric gastroenterologist Athos Bousvaros, MD, MPH. Gastrointestinal bleeding in infants is a fairly common problem, often the result of a change in diet or possibly a food allergy. Because Felix was still in the nursing stage, Bousvaros had Jessica remove some potential allergy triggers from her diet to keep traces of them from eventually ending up in her breast milk, and in turn, i...
Source: Thrive, Children's Hospital Boston - September 27, 2013 Category: Pediatrics Authors: Tripp Underwood Tags: All posts Diseases & conditions Our patients’ stories Bousvaros Inflammatory Bowel Disease Inflammatory Bowel Disease Center our patients' stories Source Type: news